Squarepoint Ops LLC Orgenesis Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.9 $60,458 - $113,503	-23,164 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $52,867 - $62,521	-11,493 Reduced 33.16%	23,164 $115,000
Q2 2021 Aug 16, 2021	BUY	$4.19 - $5.88 $145,212 - $203,783	34,657 New	34,657 $176,000
Q1 2021 May 17, 2021	SELL	$4.77 - $8.08 $78,809 - $133,497	-16,522 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.4 - $5.63 $29,308 - $37,501	-6,661 Reduced 28.73%	16,522 $74,000

Q3 2020 Nov 16, 2020	BUY	$4.75 - $5.99 $110,119 - $138,866	23,183 New	23,183 $117,000
Q2 2019 Aug 14, 2019	SELL	$3.86 - $5.2 $74,563 - $100,448	-19,317 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.28 - $5.6 $82,676 - $108,175	19,317 New	19,317 $103,000

1.63M

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $15.3M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.